```json
{
"content": [
{
"type": "paragraph",
"content": "The Compounding Pharmacy market refers to the creation of customized medications by pharmacists to meet specific patient needs, bypassing mass-produced drug formulations. As personalized healthcare gains traction, the market is witnessing accelerated demand across hospitals, clinics, and retail pharmacies. The global Compounding Pharmacy market size reached $4.8 billion in 2025, with a projected CAGR of 7.2% from 2026 to 2033, driven by rising chronic disease prevalence, advancements in personalized medicine, and regulatory support for niche therapeutic solutions."
},
{
"type": "chart",
"chartType": "segment-stacked",
"data": {
"segments": ["Hormonal", "Topical", "Sterile", "Others"],
"periods": ["2021", "2022", "2023", "2024", "2025", "2026", "2027", "2028", "2029", "2030", "2031", "2032", "2033"],
"values": [
[1200, 1250, 1320, 1400, 1480, 1570, 1660, 1760, 1870, 1980, 2100, 2230, 2370], // Hormonal
[900, 920, 950, 980, 1010, 1050, 1090, 1130, 1180, 1230, 1280, 1340, 1400], // Topical
[800, 830, 870, 910, 950, 1000, 1050, 1110, 1170, 1240, 1310, 1390, 1480], // Sterile
[500, 520, 540, 560, 580, 610, 640, 680, 720, 760, 800, 850, 900] // Others
]
}
},
{
"type": "paragraph",
"content": "Key forces shaping the industry expansion include technological innovations in 3D-printed medications and AI-driven formulation tools, alongside evolving FDA guidelines ensuring quality standards for compounded drugs. North America dominates the market (42% share in 2025) due to established healthcare infrastructure and high R&D investment, while Asia-Pacific is the fastest-growing region (9.5% CAGR), fueled by urbanization and rising demand for affordable, tailored therapies. Strategic partnerships between compounding pharmacies and biotech firms are expected to further accelerate the market forecast through 2033."
}
]
}
```
